ASO Author Reflections: Neoadjuvant Therapies for Esophageal Cancer—Where to Next?
Crossref DOI link: https://doi.org/10.1245/s10434-026-19253-5
Published Online: 2026-02-09
Published Print: 2026-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fleming, Andrew M. https://orcid.org/0000-0001-5421-9014
Ng, Thomas
Yakoub, Danny
Text and Data Mining valid from 2026-02-09
Version of Record valid from 2026-02-09
Article History
Received: 28 January 2026
Accepted: 28 January 2026
First Online: 9 February 2026
Disclosure
: The authors declare no financial disclosures or conflicts of interest related to the research described in this manuscript.